Reply to "Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era".

Lang, Claudia Cécile Valérie; Schmid-Grendelmeier, Peter; Maverakis, Emanual; Brüggen, Marie-Charlotte

Reply to "Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era".

Lang, Claudia Cécile Valérie; Schmid-Grendelmeier, Peter; Maverakis, Emanual; Brüggen, Marie-Charlotte.

Lang CCV; Faculty of Medicine, University of Zurich, Zurich, Switzerland; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Schmid-Grendelmeier P; Faculty of Medicine, University of Zurich, Zurich, Switzerland; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland; Christine Kühne Center for Allergy Research and Education CK-CARE, Davos, Switzerland.
Maverakis E; Department of Dermatology, University of California, Davis, Sacramento, Calif.
Brüggen MC; Faculty of Medicine, University of Zurich, Zurich, Switzerland; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland; Christine Kühne Center for Allergy Research and Education CK-CARE, Davos, Switzerland. Electronic address: marie-charlotte.brueggen@usz.ch.

J Allergy Clin Immunol Pract ; 9(9): 3531-3532, 2021 09.

Article in English | MEDLINE | ID: covidwho-1309267

Subject(s)

Anti-Asthmatic Agents; COVID-19; Antibodies, Monoclonal, Humanized; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Asthmatic Agents / COVID-19 Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2021 Document Type: Article Affiliation country: J.jaip.2021.06.048

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google